SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Intrepid1 who wrote (1129)6/14/1999 5:56:00 PM
From: Saracen   of 1185
 
This posting brings up an interesting point:

If NRT has a significant number of US shareholders, do not be surprised if we see a class-action lawsuit thrown NRT's way - there may be many "ambulance-chasing" lawyers out there who would love to get their hands on NRT's cash horde.

Even without a class-action lawsuit, I think that NRT's stock will under-perform for many months to come, regardless of what new partners they bring in, and this is because the company has blown any credibility that it had - management was telling everyone that the Hoffman LaRoche deal was basically done, when obviously it was not.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News